This report from Life Science Intelligence provides the latest market data for the Global Electrosurgical Devices Market. Information covered by this report includes:
The global market for electrosurgical devices was valued at an estimated $6.4 billion in 2020 and is projected to increase at a CAGR (2020-2024) of 11.2%. Product segments covered by this report include electrosurgical forceps, pencils, scalpels, and ablation devices employing monopolar and bipolar radiofrequency and plasma energy (including robotic electrosurgical instruments).
This report covers the impact of COVID-19 on the electrosurgical devices market, including a recent forecast from 2020 to 2024. COVID-19 has also impacted leading competitors, such as Condmed, Johnson & Johnson subsidiary Ethicon, Intuitive Surgical, Medtron, Smith & Nephew, and others. The report provides insights into trends, drivers, and limiters of the electrosurgical devices market, as well as highlights potential opportunities.
The electrosurgical devices market was negatively impacted by the COVID-19 pandemic. The pandemic has affected elective surgical procedures markedly, as many non-critical procedures have been cancelled or postponed so that healthcare resources have been conserved for the treatment of COVID-19 and other critically ill patients.
The leading companies in the electrosurgical devices for open surgery are Medtronic and Erbe; Ethicon (J&J) Olympus, Smith & Nephew, and Karl Storz for minimally invasive surgery; and Intuitive Surgical for robotic surgery electrosurgical.